Permanent closure notice must include which information?

Permanent closure notice must include which information?

• A. Date of closure; name and address of person(s) with custody of rx files; bulk compounding records; repackaging records; controlled substance inventory records; and name/address of person(s) acquiring any legend drugs
• B. Date of closure only
• C. Names of owners and staff
• D. DEA numbers and facility license numbers

Answer: (A)

When a pharmacy closes permanently, the notice must provide information that ensures patients’ records and regulated materials are properly handled after the shutdown. The date of closure establishes when the transition begins, but more is needed to protect patient access to records and to maintain accountability for drugs and documentation. Identifying the person or entity with custody of prescription files is essential because patients, prescribers, and regulators may need to access or transfer those records. Including details about where the bulk compounding records, repackaging records, and the controlled substance inventory will be kept or transferred ensures those important documents remain available for regulatory compliance and patient safety. Also, naming the address of the person(s) acquiring any legend drugs shows who will take custody of those medications, preventing improper disposal or diversion. A closure notice that mentions only the date would leave gaps in responsibility, record availability, and substance accountability, which is why the comprehensive information in this option is the correct and best choice.

When a pharmacy closes permanently, the notice must provide information that ensures patients’ records and regulated materials are properly handled after the shutdown. The date of closure establishes when the transition begins, but more is needed to protect patient access to records and to maintain accountability for drugs and documentation.

Identifying the person or entity with custody of prescription files is essential because patients, prescribers, and regulators may need to access or transfer those records. Including details about where the bulk compounding records, repackaging records, and the controlled substance inventory will be kept or transferred ensures those important documents remain available for regulatory compliance and patient safety. Also, naming the address of the person(s) acquiring any legend drugs shows who will take custody of those medications, preventing improper disposal or diversion.

A closure notice that mentions only the date would leave gaps in responsibility, record availability, and substance accountability, which is why the comprehensive information in this option is the correct and best choice.